References
- Imaz I, Zegarra P, Gonzalez-Enriquez J, et al. Poor bisphosphonate adherence for treatment of osteoporosis increases fracture risk: systematic review and meta-analysis. Osteoporos Int 2010;21:1943-51
- Rabenda V, Hiligsmann M, Reginster JY. Poor adherence to oral bisphosphonate treatment and its consequences: a review of the evidence. Expert Opin Pharmacother 2009;10:2303-15
- Siris ES, Selby PL, Saag KG, et al. Impact of osteoporosis treatment adherence on fracture rates in North America and Europe. Am J Med 2009;122(Suppl 2):S3-13
- Hiligsmann M, Rabenda V, Bruyere O, et al. The clinical and economic burden of non-adherence with oral bisphosphonates in osteoporotic patients. Health Policy 2010;96:170-7
- Landfeldt E, Lundkvist J, Strom O. The societal burden of poor persistence to treatment of osteoporosis in Sweden. Bone 2011;48:380-8
- Hiligsmann M, McGowan B, Bennett K, et al. The clinical and economic burden of poor adherence and persistence with osteoporosis medications in Ireland. Value Health 2012;15:604-12
- Hiligsmann M, Rabenda V, Gathon HJ, et al. Potential clinical and economic impact of nonadherence with osteoporosis medications. Calcif Tissue Int 2010;86:202-10
- Nogues, X, Rentero ML, Rodríguez AL. Use of an educational support program to assist patients receiving injectable osteoporosis treatment: experience with teriparatide. Curr Med Res Opin 2014;30:287-296
- Arden NK, Earl S, Fisher DJ, et al. Persistence with teriparatide in patients with osteoporosis: the UK experience. Osteoporos Int 2006;17:1626-9
- Briot K, Ravaud P, Dargent-Molina P, et al. Persistence with teriparatide in postmenopausal osteoporosis; impact of a patient education and follow-up program: the French experience. Osteoporos Int 2009;20:625-30
- Hiligsmann M, Salas M, Hughes DA, et al. Interventions to improve osteoporosis medication adherence and persistence: a systematic review and literature appraisal by the ISPOR Medication Adherence & Persistence Special Interest Group. Osteoporos Int 2013; [Epub Ahead of Print]
- Solomon DH, Iversen MD, Avorn J, et al. Osteoporosis telephonic intervention to improve medication regimen adherence: a large, pragmatic, randomized controlled trial. Arch Intern Med 2012;172:477-83
- Hugtenburg JG, Timmers L, Elders PJM, et al. Definitions, variants, and causes of nonadherence with medication: a challenge for tailored interventions. Patient Prefer Adherence 2013;7:675-82
- Tan AM, Lamontagne AD, Sarmugam R, et al. A cluster-randomised, controlled trial to assess the impact of a workplace osteoporosis prevention intervention on the dietary and physical activity behaviours of working women: study protocol. BMC Public Health 2013;13:405
- Drieling RL, Ma J, Thiyagarajan S, et al. An Internet-based osteoporotic fracture risk program: effect on knowledge, attitudes, and behaviors. J Womens Health (Larchmt) 2011;20:1895-907
- McHorney CA, Gadkari AS. Individual patients hold different beliefs to prescription medications to which they persist vs nonpersist and persist vs nonfulfill. Patient Prefer Adherence 2010;4:187-95
- Sedlak CA, Doheny MO, Estok PJ, et al. Tailored interventions to enhance osteoporosis prevention in women. Orthop Nurs 2005;24:270-6; quiz 7–8
- Blalock SJ, DeVellis BM, Patterson CC, et al. Effects of an osteoporosis prevention program incorporating tailored educational materials. Am J Health Promot 2002;16:146-56
- Hiligsmann M, Kanis JA, Compston J, et al. Health technology assessment in osteoporosis. Calcif Tissue Int 2013;93:1-14
- Patrick AR, Schousboe JT, Losina E, et al. The economics of improving medication adherence in osteoporosis: validation and application of a simulation model. J Clin Endocrinol Metab 2011;96:2762-70